NasdaqGS - Delayed Quote USD

Utah Medical Products, Inc. (UTMD)

67.92 +0.63 (+0.94%)
At close: May 3 at 4:00 PM EDT
67.92 0.00 (0.00%)
After hours: May 3 at 4:20 PM EDT
Loading Chart for UTMD
DELL
  • Previous Close 67.29
  • Open 67.12
  • Bid 67.35 x 100
  • Ask 68.01 x 200
  • Day's Range 67.08 - 68.57
  • 52 Week Range 65.91 - 100.59
  • Volume 9,476
  • Avg. Volume 31,658
  • Market Cap (intraday) 243.72M
  • Beta (5Y Monthly) 0.13
  • PE Ratio (TTM) 15.09
  • EPS (TTM) 4.50
  • Earnings Date Jul 23, 2024 - Jul 29, 2024
  • Forward Dividend & Yield 1.20 (1.77%)
  • Ex-Dividend Date Mar 14, 2024
  • 1y Target Est --

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

www.utahmed.com

169

Full Time Employees

December 31

Fiscal Year Ends

Recent News: UTMD

Performance Overview: UTMD

Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

UTMD
19.01%
S&P 500
7.50%

1-Year Return

UTMD
27.13%
S&P 500
24.47%

3-Year Return

UTMD
17.72%
S&P 500
22.64%

5-Year Return

UTMD
11.36%
S&P 500
75.76%

Compare To: UTMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UTMD

Valuation Measures

Annual
As of 5/3/2024
  • Market Cap

    243.72M

  • Enterprise Value

    150.20M

  • Trailing P/E

    15.08

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.03

  • Price/Book (mrq)

    1.91

  • Enterprise Value/Revenue

    3.06

  • Enterprise Value/EBITDA

    9.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    33.39%

  • Return on Assets (ttm)

    8.49%

  • Return on Equity (ttm)

    13.33%

  • Revenue (ttm)

    49.04M

  • Net Income Avi to Common (ttm)

    16.38M

  • Diluted EPS (ttm)

    4.50

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    93.81M

  • Total Debt/Equity (mrq)

    0.22%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: UTMD

Company Insights: UTMD

Research Reports: UTMD

People Also Watch